Cobalt International Energy, Inc. (CIE) failed to extend gains with the stock declining -4.57% or $-0.04 to close the day at $0.79 on active trading volume of 7M shares, compared to its three month average trading volume of 5.23M. The Houston Texas 77024 based company has been underperforming the independent oil & gas group over the past 52 weeks, with the stock losing -68.81%, compared to the industry which has advanced 44.3% over the same period. With RSI of 32.96, the stock should still continue to rise and get closer to its one year target estimate of $2.69, making it a hold for now.
Cobalt International Energy, Inc., through its subsidiaries, operates as an oil and gas exploration and production company primarily in the deepwater U.S. Gulf of Mexico. The company holds interests in the North Platte, Shenandoah, Anchor, and Heidelberg fields located in the U.S. Gulf of Mexico; and the Diaba block located offshore Gabon. As of December 31, 2015, it had net proved undeveloped reserves of 5.6 million barrels (MMBbls) of oil; 0.3 MMBbls of natural gas liquids; and 1.8 billion cubic feet of natural gas. The company was founded in 2005 and is based in Houston, Texas.
Mast Therapeutics, Inc. (MSTX) fell -3.99% during last trading as the stock lost $-0.01 to finish the day at $0.13 with about 6.78M shares changing hands, compared to its three month average trading volume of 9.69M. The $28.67M market cap company, which fluctuated between $0.13 and $0.14 during the day, currently situated 85.71% above its 52 week low of $0.07 and -81.69% away from its one year high of $0.71. The RSI of 48.7 indicates the stock is neither overvalued nor undervalued at the current levels, hold for now.
Mast Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops therapies for serious or life-threatening diseases with significant unmet needs. The company’s lead product candidate is MST-188 (vepoloxamer), an injection used for the treatment of sickle cell disease, arterial disease, and heart failure. It also develops AIR001, a sodium nitrite solution for intermittent inhalation via nebulizer, as well as for the treatment of heart failure with preserved ejection fraction. The company was formerly known as ADVENTRX Pharmaceuticals, Inc. and changed its name to Mast Therapeutics, Inc. in March 2013. Mast Therapeutics, Inc. was founded in 1995 and is headquartered in San Diego, California.
Pandora Media, Inc. (P) saw its value decrease by -0.52% as the stock dropped $-0.07 to finish the day at a closing price of $13.45. The stock was lighter in trading and has fluctuated between $8.05-$14.98 per share for the past year. The shares, which traded within a range of $13.31 to $13.67 during the day, are up by 26.17% in the past three months and up by 2.59% over the past six months. It is currently trading 2.55% above its 20 day moving average and 2.82% above its 50 day moving average. Analysts believe the company can continue to increase in value to reach at $14.59 a share over the next twelve months. The current relative strength index (RSI) reading is 59.39. The technical indicator lead us to believe there will be no major movement any time soon, hold.
Pandora Media, Inc. provides Internet music streaming services in North America. The company allows its listeners to create personalized stations to access free music and comedy catalogs, as well as personalized playlist generating system; and offers Pandora One, a paid subscription service to listeners. It also sells audio, display, and video advertising to advertisers for delivery on computer, mobile, and other connected device platforms. In addition, the company offers ticketing and marketing software and services for venues and event promoters to promote their events, as well as allow fans to find and purchase tickets for events. Pandora Media, Inc. was founded in 2000 and is headquartered in Oakland, California.